Adam Barker, PhD, director of the ARUP Institute for Clinical & Experimental Pathology

January 5, 2021

Adam Barker will delve into how ARUP Laboratories handled the demands and challenges brought on by the pandemic, and how the pandemic influenced innovation and research.

Adam Barker, PhD, director of the ARUP Institute for Clinical & Experimental Pathology, is among medical experts who will participate in a January 7, 2021, event sponsored by Silicon Slopes that will examine Utah’s response to COVID-19.

Barker, who is also an associate professor in the University of Utah Department of Pathology, will participate on a panel about life science innovation during the virtual event, which will engage private- and public-sector leaders to discuss how their organizations adapted and innovated to mitigate the virus’s impact on their employees, their businesses and industries, and Utah’s economy overall.

The panel on which Barker will speak will include Robert Glanzman, MD, chief medical officer of Clene Nanomedicine, and James McCullough, CEO of RenalytixAI.

Barker will address how ARUP quickly ramped up COVID-19 testing in the face of unprecedented demands and supply shortages and accelerated its research to ensure accuracy. He will also discuss some of the research and development (R&D) and implementation measures that resulted in a COVID-19 diagnostic test that could be performed on saliva, as well as ARUP’s combined test for COVID-19, influenza, and respiratory syncytial virus.

The virtual event runs from 9 a.m. to noon. Barker’s panel discussion will be from 11 to 11:30 a.m.

Viewers can tune in via Silicon Slopes’ FacebookTwitter, or LinkedIn accounts, or on its YouTube channel here. For more information, visit the Silicon Slopes website.

Peta Owens-Liston, Sr. Science Communications Writer